In cancer, the association between APOE and hormone effects has not been extensively investigated, yet studies have shown that APOE ε2 may be protective against cognitive decline following chemotherapy for breast cancer in older patients [197], whilst APOE ε4 carriers may be at greater risk [198]. This evidence concerns the gene APOE and breast cancer.